The time has come for harmonized international ART registration
Research output: Contribution to journal › Comment/debate › Research › peer-review
Standard
The time has come for harmonized international ART registration. / Pinborg, Anja; Blockeel, Christophe; Campbell, Alison; Coticchio, Giovanni; Garcia-Velasco, Juan A.; Santulli, Pietro; De Geyter, Christian; Wyns, Christine.
In: Reproductive BioMedicine Online, Vol. 46, No. 6, 2023, p. 881-885.Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The time has come for harmonized international ART registration
AU - Pinborg, Anja
AU - Blockeel, Christophe
AU - Campbell, Alison
AU - Coticchio, Giovanni
AU - Garcia-Velasco, Juan A.
AU - Santulli, Pietro
AU - De Geyter, Christian
AU - Wyns, Christine
N1 - Publisher Copyright: © 2023
PY - 2023
Y1 - 2023
N2 - For more than two decades, the European IVF-Monitoring Consortium has collected data on IVF in Europe with the aim of monitoring the quality and safety of assisted reproductive technology (ART) treatments, to ensure the highest performance with the lowest risk for patients and their offspring. Likewise, the Society for Assisted Reproductive Technology in the USA and the Australia/New Zealand Assisted Reproduction Database collect, process and publish data in their regions. The better the legal framework for ART surveillance, the more complete and reliable are the datasets. Worldwide, the landscape of ART regulation is fragmented, and until there is a legal obligation to report ART data in all countries, with an appropriate quality control of the data collected, the reported outcomes should be interpreted with caution. Once uniform and harmonized data are achieved, consensus reports based on collective findings can begin to address key topics such as cycle segmentation and complications. Improved registration systems and datasets allowing optimized surveillance should be developed in collaboration with patient representatives to consider patients’ needs, especially aiming to provide higher transparency around ART services. Support from national and international reproductive medicine societies will also be essential to the future evolution of ART registries.
AB - For more than two decades, the European IVF-Monitoring Consortium has collected data on IVF in Europe with the aim of monitoring the quality and safety of assisted reproductive technology (ART) treatments, to ensure the highest performance with the lowest risk for patients and their offspring. Likewise, the Society for Assisted Reproductive Technology in the USA and the Australia/New Zealand Assisted Reproduction Database collect, process and publish data in their regions. The better the legal framework for ART surveillance, the more complete and reliable are the datasets. Worldwide, the landscape of ART regulation is fragmented, and until there is a legal obligation to report ART data in all countries, with an appropriate quality control of the data collected, the reported outcomes should be interpreted with caution. Once uniform and harmonized data are achieved, consensus reports based on collective findings can begin to address key topics such as cycle segmentation and complications. Improved registration systems and datasets allowing optimized surveillance should be developed in collaboration with patient representatives to consider patients’ needs, especially aiming to provide higher transparency around ART services. Support from national and international reproductive medicine societies will also be essential to the future evolution of ART registries.
KW - ART registration
KW - Europe
KW - IVF data monitoring
KW - Registries
KW - Reproductive outcomes
KW - Surveillance
U2 - 10.1016/j.rbmo.2023.02.015
DO - 10.1016/j.rbmo.2023.02.015
M3 - Comment/debate
C2 - 37024399
AN - SCOPUS:85151664866
VL - 46
SP - 881
EP - 885
JO - Reproductive BioMedicine Online
JF - Reproductive BioMedicine Online
SN - 1472-6483
IS - 6
ER -
ID: 363399293